Navigation Links
Akron researcher awarded NIH grant for advancing 3-D tumor models for anticancer drug testing
Date:10/31/2013

The National Institutes of Health is supporting the work of a University of Akron researcher who may hold the key to improving the effectiveness of cancer treatments. The agency has awarded UA's Hossein Tavana a two-year, $511,000 grant to fund his ongoing efforts to improve the testing and effectiveness of anticancer drugs.

Tavana, an assistant professor of biomedical engineering in the College of Engineering, has developed a method to generate 3-D cultures of cancer cells (spheroids) that better model tumors in the body. These improved models have the potential to dramatically improve the screening and discovery of effective chemotherapeutics, Tavana says.

In support of this novel and promising technology, the NIH awarded Tavana its R21 grant, which is defined by the NIH as a developmental research grant intended to support "exploratory, novel studies that break new ground or extend previous discoveries toward new directions or applications."

Drug testing on 2-D cultures of cancer cells, in which thin layers of cells are treated on a flat dish, does not adequately predict how the drugs will behave in the 3-D environment of the body, Tavana says.

Three-dimensional cultures, on the other hand, in which cancer cells aggregate into spherical clusters, better mimic tumors, allowing for more efficient and cost-effective drug screening and discovery, he adds.

This in turn allows researchers to determine which drugs will best treat particular forms of cancer, eliminating the need to treat patients with a battery of drugs in the hope of finding something that works, Tavana explains.

"Rather than throwing a bunch of different drugs into a patient's body, we can say, 'This particular patient, based on this test, will most likely benefit from this chemo drug.'"

Whereas other labs are generating 3-D cancer cell spheroids, or aggregates, one at a time, Hossein's unique method allows him to generate 384 spheroids "robotically and in a single step," drastically expediting drug testing.

The robot, equipped with rows of pipettes, dispenses cancer cells into 384 small wells, or miniature test tubes, each of which contains a liquid that provides nutrients to the immersed cells, allowing them to aggregate as they would in the body, resulting in 384 physiologic tumor models.

Tavana and his research team are currently testing cell lines cells that have been made immortal so they can be reused over and over of triple negative breast cancer cells and skin cancer. Next year they plan to use primary, patient-derived cells, which will allow them to test drugs under more realistic conditions.


'/>"/>

Contact: Denise Henry
henryd@uakron.edu
330-972-6477
University of Akron
Source:Eurekalert  

Related medicine news :

1. Akron General President & CEO deemed 2013 Wellness Warrior
2. Akron General Health System, Kent State University Form Health and Wellness Research Collaborative
3. CottageCare® Akron Now Offers Patio Cleaning
4. Akron researchers devise Rx for ailing wellness programs
5. UTSA researchers develop prototype football kicking simulator
6. CWRU researchers aim nanotechnology at micrometastases
7. Risk of osteoporosis drugs side effects not significant, Loyola researchers find
8. New look at old test may provide earlier detection of meningitis, MU researchers find
9. MUHC researchers identify biomarkers that could leadto early diagnosis of colorectal cancer
10. Unpublished trial data violates an ethical obligation to study participants, say researchers
11. Einstein researchers lead panels at NIH Aging and Chronic Disease Symposium on Geroscience
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Akron researcher awarded NIH grant for advancing 3-D tumor models for anticancer drug testing
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, ... organization dedicated to helping service members that have been wounded in battle and their ...
(Date:6/24/2016)... ... 2016 , ... To succeed under value-based payments, healthcare providers ... how to move forward, given the need to sustain current operations. PYA has ... an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare providers want ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
(Date:6/23/2016)... , June 23, 2016  Experian Health, ... and transforming the patient payment and care ... innovative new products and services that will ... revenue cycle offerings. These award-winning solutions will ... workflows, remain compliant in an ever-changing environment ...
Breaking Medicine Technology: